期刊
JOURNAL OF PAIN
卷 17, 期 9, 页码 T93-T107出版社
CHURCHILL LIVINGSTONE
DOI: 10.1016/j.jpain.2016.06.002
关键词
Overlapping conditions; diagnosis; classification; pain sensitivity; psychological factors; genetic factors
资金
- U.S. Food and Drug Administration (FDA)
- ACTTION public-private partnership, from the FDA
- NIH [U01DE017018, DE016558, P01N5045685, R01DE016155, K12DE022793]
There is increasing recognition that many if not most common chronic pain conditions are heterogeneous with a high degree of overlap or coprevalence of other common pain conditions along with influences from biopsychosocial factors. At present, very little attention is given to the high degree of overlap of many common pain conditions when recruiting for clinical trials. As such, many if not most patients enrolled into clinical studies are not representative of most chronic pain patients. The failure to account for the heterogeneous and overlapping nature of most common pain conditions may result in treatment responses of small effect size when these treatments are administered to patients with chronic overlapping pain conditions (COPCs) represented in the general population. In this brief review we describe the concept of COPCs and the putative mechanisms underlying COPCs. Finally, we present a series of recommendations that will advance our understanding of COPCs. Perspective: This brief review describes the concept of COPCs. A mechanism-based heuristic model is presented and current knowledge and evidence for COPCs are presented. Finally, a set of recommendations is provided to advance our understanding of COPCs. (C) 2016 by the American Pain Society
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据